These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer. Hedayati M; Zarif Yeganeh M; Sheikholeslami S; Afsari F Crit Rev Clin Lab Sci; 2016 Aug; 53(4):217-27. PubMed ID: 26678667 [TBL] [Abstract][Full Text] [Related]
5. Molecular Targeted Therapies of Aggressive Thyroid Cancer. Ferrari SM; Fallahi P; Politti U; Materazzi G; Baldini E; Ulisse S; Miccoli P; Antonelli A Front Endocrinol (Lausanne); 2015; 6():176. PubMed ID: 26635725 [TBL] [Abstract][Full Text] [Related]
8. Perspectives on the Treatment of Advanced Thyroid Cancer: Approved Therapies, Resistance Mechanisms, and Future Directions. Porter A; Wong DJ Front Oncol; 2020; 10():592202. PubMed ID: 33569345 [TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Viola D; Valerio L; Molinaro E; Agate L; Bottici V; Biagini A; Lorusso L; Cappagli V; Pieruzzi L; Giani C; Sabini E; Passannati P; Puleo L; Matrone A; Pontillo-Contillo B; Battaglia V; Mazzeo S; Vitti P; Elisei R Endocr Relat Cancer; 2016 Apr; 23(4):R185-205. PubMed ID: 27207700 [TBL] [Abstract][Full Text] [Related]
10. BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review. Şahpaz A; Önal B; Yeşilyurt A; Han Ü; Delibaşı T Balkan Med J; 2015 Apr; 32(2):156-66. PubMed ID: 26167339 [TBL] [Abstract][Full Text] [Related]
11. Lenvatinib: Role in thyroid cancer and other solid tumors. Cabanillas ME; Habra MA Cancer Treat Rev; 2016 Jan; 42():47-55. PubMed ID: 26678514 [TBL] [Abstract][Full Text] [Related]
12. An update on molecular biology of thyroid cancers. Omur O; Baran Y Crit Rev Oncol Hematol; 2014 Jun; 90(3):233-52. PubMed ID: 24405857 [TBL] [Abstract][Full Text] [Related]
13. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma. Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560 [TBL] [Abstract][Full Text] [Related]
18. New molecular targeted therapies in thyroid cancer. Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797 [TBL] [Abstract][Full Text] [Related]